Summary
GlobalData's clinical trial report, “Thymic Carcinoma Global Clinical Trials Review, H2, 2016" provides an overview of Thymic Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Thymic Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Eli Lilly and Company
Tiziana Life Sciences Plc
Onxeo SA
Nerviano Medical Sciences S.r.l.
Merrimack Pharmaceuticals, Inc.
Merck & Co., Inc.
Karyopharm Therapeutics, Inc.
Eisai Co., Ltd.
Celgene Corporation
AstraZeneca Plc
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of Thymic Carcinoma to Oncology Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by E7 Countries: Proportion of Thymic Carcinoma to Oncology Clinical Trials 14
Clinical Trials in E7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Thymic Carcinoma Therapeutics Clinical Trials 23
Prominent Drugs 25
Latest Clinical Trials News on Thymic Carcinoma 26
Oct 10, 2016: ESMO 2016: Clinical Benefit Demonstrated with Everolimus and Pasireotide LAR Alone or in Combination in the First Randomised, Prospective Study Entirely Dedicated to Advanced Lung and Thymic Carcinoids 26
Clinical Trial Profile Snapshots 27
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 59
List of Tables
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Region, 2016* 5
Thymic Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Thymic Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Thymic Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Thymic Carcinoma Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9
Thymic Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Proportion of Thymic Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2016* 11
Thymic Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Thymic Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
Proportion of Thymic Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2016* 14
Thymic Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 15
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2016* 16
Thymic Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 17
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 18
Thymic Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 19
Thymic Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 20
Thymic Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 21
Thymic Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
Thymic Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Thymic Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
List of Figures
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Thymic Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Thymic Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Thymic Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
Thymic Carcinoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9
Thymic Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Proportion of Thymic Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2016* 11
Thymic Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Thymic Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
Proportion of Thymic Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2016* 14
Thymic Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 15
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 16
Thymic Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 17
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 18
Thymic Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 19
Thymic Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 20
Thymic Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 21
Thymic Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
Thymic Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 23
Thymic Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
GlobalData Methodology 57
